|
|
 | | | |
- close
- close
- close
- close
Ardea Biosciences Inc (RDEA) |
Marketwire
Jun 20
Comment
SAN DIEGO, CA -- (Marketwire) -- 06/20/12 -- AstraZeneca today announced that on Tuesday, June 19, 2012 it completed its acquisition of San Diego, California-based biotechnology company Ardea Biosciences, Inc. The merger was approved by Ardea's
Marketwire
Jun 5
Comment
SAN DIEGO, CA -- (Marketwire) -- 06/05/12 -- Ardea Biosciences, Inc. (NASDAQ: RDEA) ("Ardea"), a biotechnology company focused on the development of small-molecule therapeutics for the treatment of serious diseases, today announced the expiration of
Marketwire
May 30
Comment
SAN DIEGO, CA -- (Marketwire) -- 05/30/12 -- Ardea Biosciences, Inc. (NASDAQ: RDEA) today announced that it has earned a $7.5 million milestone from Bayer HealthCare (Bayer) under the terms of their April 2009 global license agreement to develop and
StreetInsider.com
May 7
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Ardea+Biosciences%2C+Inc.+%28RDEA%29+Reports+Q1+Loss+of+%241.25Share/7407662.html for the full story.
Marketwire
May 7
Comment
SAN DIEGO, CA -- (Marketwire) -- 05/07/12 -- Ardea Biosciences, Inc. (NASDAQ: RDEA), a biotechnology company focused on the development of small-molecule therapeutics for the treatment of serious diseases, today announced first quarter 2012 financial
Marketwire
Apr 26
Comment
NEW YORK, NY -- (Marketwire) -- 04/26/12 -- Levi & Korsinsky notifies investors of Ardea Biosciences, Inc. ("Ardea" or the "Company") (NASDAQ: RDEA) for possible breaches of fiduciary duty and other violations of state law against the board of
Benzinga
Apr 23
Comment
In recent years, traders and investors have increasingly turned to social media to discuss their investments. Now, interested parties can get a scientific look at what is being discussed on a weekly, monthly, and even hourly basis.
Provided by...
Benzinga
Apr 23
Comment
Shares of Ardea Biosciences (NASDAQ: RDEA) are seeing much strength after the company announced it has entered into a definitive merger agreement with AstraZeneca (NYSE: AZN) for about $1.26 billion.
Under the terms of the agreement,...
Benzinga
Apr 23
Comment
Ardea Biosciences Inc (NASDAQ: RDEA) surged 51.87% to $31.65 in the pre-market session. Ardea Biosciences agreed to be bought by AstraZeneca PLC (NYSE: AZN) or $32 per share.
Amylin Pharmaceuticals Inc (NASDAQ: AMLN) added 10.38% to $25.30 in...
Wall Street Journal
Apr 23
Comment
U.K. drug maker AstraZeneca is buying U.S.-based Ardea Biosciences for $1.26 billion, a deal that will expand its thin pipeline of new medicines.
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_2/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800. |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
